PD-L1 is an activation-independent marker of brown adipocytes
Programmed death ligand 1 (PD-L1) is expressed on a number of immune and cancer cells, where it can downregulate antitumor immune responses. Its expression has been linked to metabolic changes in these cells. Here we develop a radiolabeled camelid single-domain antibody (anti-PD-L1 VHH) to track PD-...
Main Authors: | Ingram, Jessica R., Dougan, Michael, Rashidian, Mohammad, Knoll, Marko, Keliher, Edmund J., Garrett, Sarah, Garforth, Scott, Blomberg, Olga S., Espinosa, Camilo, Bhan, Atul, Almo, Steven C., Weissleder, Ralph, Dougan, Stephanie K., Lodish, Harvey F, Ploegh, Hidde |
---|---|
Other Authors: | Massachusetts Institute of Technology. Department of Biology |
Format: | Article |
Published: |
Springer Nature
2018
|
Online Access: | http://hdl.handle.net/1721.1/115203 https://orcid.org/0000-0002-7029-7415 https://orcid.org/0000-0002-1090-6071 |
Similar Items
-
MicroRNA networks regulate development of brown adipocytes
by: Trajkovski, Mirko, et al.
Published: (2016) -
Use of [superscript 18]F‑2-Fluorodeoxyglucose to Label Antibody Fragments for Immuno-Positron Emission Tomography of Pancreatic Cancer
by: Keliher, Edmund J., et al.
Published: (2017) -
Noninvasive imaging of immune responses
by: Rashidian, Mohammad, et al.
Published: (2016) -
De Novo Reconstruction of Adipose Tissue Transcriptomes Reveals Long Non-coding RNA Regulators of Brown Adipocyte Development
by: Bai, Zhiqiang, et al.
Published: (2016) -
Durable antitumor responses to CD47 blockade require adaptive immune stimulation
by: Sockolosky, Jonathan T., et al.
Published: (2016)